In May 2025, Recursion scientists released a paper outlining this vision, “ Virtual Cells: Predict, Explain, Discover,” which detailed a digital cell model that can reliably simulate patient ...

Is Recursion Pharma a buy because of Nvidia’s endorsement? Indeed, Nvidia’s bet on Recursion is notable, but despite the stake and collaboration, the name isn’t without its fair share of risks.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for the Next 5 Years. On August 5, Needham reiterated its Buy rating on Recursion Pharmaceuticals, Inc ...

According to data compiled by S&P Global Market Intelligence, Recursion Pharmaceuticals (NASDAQ: RXRX) stock was shedding more than 17% of its value week-to-date as of Thursday night.

Explore RXRX's upcoming H2'25 trial updates for REC-4881 in familial adenomatous polyposis and REC-617.

Stay up-to-date on Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq.com.

Find annual and quearterly earnings data for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) including earnings per share, earnings forecasts at Nasdaq.com.

Breaking down the ending of 'Weapons': Where did all of those kids go and what happened to them?

Weapons, the latest from Barbarian director Zach Cregger, is here and we are breaking down its explosive finale.

After a video went viral showing a whale trainer named Jessica Radcliffe being killed in front of an audience, the video was debunked as being AI-generated.